AI CAPITAL INTELLIGENCE
荷塘创投 | Institution profile
Institution at a glance
Hetang Venture Capital says it focuses on innovative companies with core hard technologies. Its Hetang Innovation Fund II was registered in 2023 with a target size of CNY 500 million and a strategy centered on technology transfer and first-of-kind technologies. That is one fund’s target size, not the manager’s total assets under management.
Source verification date: · The CNY 500 million target applies to Hetang Innovation Fund II only. The financing source linked to Huayiyingfei describes a December 2019 angel round and does not support the database’s current 2026 pre-Series A attribution. Hetang’s 2026 lead investment in Wuzhinsong Pharma is a separate round.
Names follow their disclosed form. Descriptive English renderings of Chinese names are not verified legal names. Original quotations are shown in their source language.
Key facts
| Investment focus | Innovative companies built on core hard technologies; technology transfer and first-of-kind technologies. |
|---|---|
| Named fund | Hangzhou Hetang Innovation Hangshi Technology Transfer Venture Fund (LP), also known as Hetang Innovation Fund II; registered May 5, 2023, with a CNY 500 million target size. |
Public record
- Hetang’s official news center reported that it led Wuzhinsong Pharma’s July 2026 angel round. The company’s several-tens-of-millions-yuan round total is not Hetang’s individual commitment.
- The linked 36Kr project page records Hetang as an investor in Huayiyingfei’s December 2019 angel round; it does not substantiate a 2026 pre-Series A investment.
Official contact details
- Official website: Hetang Venture Capital Management (Beijing) Co., Ltd.
Sources
- 1. Hetang Venture Capital · Official website
支持技术创新驱动为核心目标，一直专注于投资拥有核心硬技术的创新型企业。Original Chinese-language excerpt
- 2. Hetang Venture Capital · Hetang Innovation Fund II
荷塘创新二期基金于2023年5月5日完成备案，目标规模5亿元，以科技成果转化及首创技术投资为主要策略。Original Chinese-language excerpt
- 3. Hetang Venture Capital · News center
2026年7月28日，五针松医药宣布完成天使轮融资，本轮融资由荷塘创投领投。Original Chinese-language excerpt
- 4. Huayiyingfei project profile · 36Kr
天使轮 2019-12 未透露 荷塘创投Original Chinese-language excerpt